FMS Financing Cash Flow

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share) · Financing Cash Flow

FMS logo

FMS Financing Cash Flow

Latest reported-€2.56B EUR
FMS TTM Cash from Financing · EUR (€165.71M → -€2.56B)
High-resolution chart · PNG

FMS financing cash flow history

Trailing twelve months (TTM) · EUR. Each value covers four complete reported quarters.

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share) Financing Cash Flow — Trailing twelve months (TTM) (EUR)
Period endingFinancing Cash Flow (EUR)
-2,556,520,828
-1,707,762,828
-1,410,464,828
-2,160,003,000
-1,501,835,000
-2,418,431,000
-2,569,300,000
-2,349,769,000
-2,285,014,000
-2,150,200,000
-1,858,529,000
-1,232,791,000
-1,322,993,000
-1,348,705,000
-1,617,360,000
-1,854,977,000
-1,640,975,000
-1,255,108,000
-1,024,382,000
-1,235,437,000
-1,640,046,000
-2,468,410,000
-2,664,027,000
-2,259,782,000
-2,091,523,000
-1,420,321,000
-466,633,000
-249,854,000
326,177,000
-297,418,000
-681,736,000
-977,772,000
-1,342,164,000
-607,177,000
-798,630,000
-827,751,223
-751,648,875
-511,053,784
-556,014,150
-641,152,883
-616,627,091
-601,011,206
-921,555,622
-144,426,494
129,608,776
358,392,045
662,008,844
208,008,195
-988,780
-308,208,238
-585,166,407
-731,424,673
-909,271,469
-800,904,939
354,130,607
819,952,972
959,625,806
1,322,030,907
611,961,825
353,794,458
362,344,837
392,339,417
-11,065,713
-129,078,663
-139,822,733
-522,585,508
-389,550,321
-298,308,760
-198,439,055
-106,049,213
-112,102,704
-104,861,755
-154,692,476
-230,924,093
-233,653,962
-444,839,068
-293,959,922
-869,259,640
2,563,029,628
2,746,504,697
2,664,755,206
3,284,234,980
-185,551,476
-231,447,086
-281,362,132
-335,257,740
-333,370,133
-332,708,823
-335,778,764
-349,877,539
-330,221,196
-358,092,614
-277,607,851
-295,829,669
-252,668,560
-231,945,607
-244,154,624
-77,786,002
48,886,712
111,320,333
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.